AstraZeneca PLC (LON:AZN)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Oncology Revenue	27.79B	25.62B	20.28B
BioPharmaceuticals: Cardiovascular, Renal & Metabolism PR (CVRM) Revenue	12.28B	12.77B	12.45B
BioPharmaceuticals: Respiratory & Immunology PR (R&I) Revenue	9.38B	8.87B	7.42B
BioPharmaceuticals Infectious Disease PR (ID) Revenue	1.17B	1.27B	1.06B
Rare Disease Revenue	9.70B	9.13B	8.67B
Other Medicines Revenue	959.00M	988.00M	1.07B
Collaboration Revenue	-	99.00M	3.14B
Revenue (Other)	94.00M	-	-
Revenue (Total)	61.37B	58.74B	54.07B

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
UK Revenue	-	4.36B	4.74B
Rest of Europe Revenue	-	13.46B	11.70B
The Americas Revenue	-	27.56B	24.99B
Asia, Africa & Australasia Revenue	-	13.37B	12.64B
Revenue (Total)	61.37B	58.74B	54.07B

EBIT by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
UK Operating Profit	-	7.07B	2.68B
Rest of Europe Operating Profit	-	5.23B	5.92B
The Americas Operating Profit	-	440.00M	423.00M
Asia, Africa & Australasia Operating Profit	-	1.00B	976.00M
Operating Income (Total)	13.97B	13.74B	10.00B

Capital Expenditures by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
UK Assets Acquired	1.76B	582.00M
Rest of Europe Assets Acquired	2.81B	2.23B
The Americas Assets Acquired	1.88B	3.93B
Asia, Africa & Australasia Assets Acquired	557.00M	1.39B

Data Source: Fiscal.ai Last updated: Jun 30, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error